Bliss GVS Pharma logo

Bliss GVS Pharma CEO, MD, chairman, board of directors and AGM

NSE: BLISSGVSBSE: 506197Pharmaceuticals & BiotechnologySmall Cap

Last close ₹623.35down ₹19.35 (3.01%)BSE ₹628.50

Share price at the NSE close on 23 Oct 2026. Previous close ₹642.70.

52-week range of traded prices to 23 Oct 2026
₹118.00Low, 10 Nov 2025₹739.90High, 28 Sep 2026
Market cap
₹6,628 Cr1,000th largest listed
P/E
48.7
P/B
5.6
Dividend yield
0.24%
ROE
12.1%
ROCE
12.3%
Debt to equity
0.00
Volume, NSE
1,58,050

Bliss GVS Pharma board of directors

At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

  • ChairpersonNandkumar Kashinath Chodankar
  • Managing director and CEONarsimha Shibroor Kamath

5 directors4 independent1 executive

  • Nandkumar Kashinath Chodankar · ChairpersonIndependent · joined Jun 2024 · reappointed Jun 2024 · 24 months as independent · 1 listed board · 1 as independent · 2 committee seats, 1 as chair
  • Narsimha Shibroor Kamath · Managing director and CEOExecutive · joined Jan 2026 · reappointed Jan 2026 · 1 listed board · 2 committee seats
  • Deepak Rameshchandra ShahIndependent · joined Apr 2026 · reappointed Apr 2026 · 2 months as independent · 4 listed boards · 3 as independent · 5 committee seats, 3 as chair
  • Vijayanarayanan MahadevanIndependent · joined Apr 2026 · reappointed Apr 2026 · 2 months as independent · 1 listed board · 1 as independent
  • Shilpa Vinodkumar BhatiaIndependent · joined Feb 2020 · reappointed Feb 2025 · 76 months as independent · 3 listed boards · 3 as independent · 3 committee seats

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

4 directors who left
  • Santosh Parab, left 25 May 2026: Tenure Completion
  • Shruti Vishal Rao, left 10 Feb 2026: Others
  • Vibha Gagan Sharman, left 10 Feb 2026: Others
  • Gagan Harsh Sharma, left 6 Nov 2025: Others

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

  • Board

    • 23 May 20265 of 5 present4 independent · 10 days in between
    • 12 May 20265 of 5 present4 independent
    • 10 Feb 20266 of 6 present3 independent

  • Audit Committee

    Chair Deepak Rameshchandra Shah

    Nandkumar Kashinath Chodankar, Narsimha Shibroor Kamath, Shilpa Vinodkumar Bhatia

    • 12 May 20263 of 3 present2 independent · 90 days in between
    • 10 Feb 20263 of 3 present3 independent

  • Nomination and remuneration committee

    Chair Vijayanarayanan Mahadevan

    Nandkumar Kashinath Chodankar, Shilpa Vinodkumar Bhatia

    • 10 Feb 20263 of 3 present3 independent
    • 12 May 20253 of 3 present3 independent

  • Stakeholders Relationship Committee

    Chair Nandkumar Kashinath Chodankar

    Shilpa Vinodkumar Bhatia, Narsimha Shibroor Kamath

    • 12 May 20263 of 3 present2 independent · 125 days in between

  • Risk Management Committee

    Chair Shilpa Vinodkumar Bhatia

    Narsimha Shibroor Kamath, Sourya Das, Deepak Sawant

    • 6 Jan 20264 of 4 present1 independent · 238 days in between

  • Corporate Social Responsibility Committee

    Chair Nandkumar Kashinath Chodankar

    Narsimha Shibroor Kamath, Shilpa Vinodkumar Bhatia

    • 12 May 20263 of 3 present2 independent

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Mar 2026.

  • Kalyaniwala & Mistry LLPPeer-review certificate valid to Jul 2027
1 earlier auditor
  • M/s Kalyaniwalla & Mistry LLPNamed in the filing for the quarter to Mar 2025

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Bliss GVS Pharma AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Bliss GVS Pharma dividend history

Postal ballot, 19 Sep 2026

46,226 shareholders on the register on 14 Aug 2026; votes counted by Mr.Vijay Yadav / AVS & Associates.The company's voting result (opens in a new tab)

  1. APPOINTMENT OF MR. SANTOSH PARAB (DIN: 01622988) AS A DIRECTOR IN THE CAPACITY OF NON-EXECUTIVE NON-INDEPENDENT DIRECTOR OF THE COMPANY.
    Ordinary
    97.04% for2.96% against

    Against: promoters 0.00% · institutions 15.53% · other public 0.00%

    Turnout: all 58.66% · promoters 87.36% · institutions 69.98% · other public 34.56%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 15 Jul 2026, 3 resolutions

47,336 shareholders on the register on 8 Jul 2026; present: 2 promoters and 70 others; votes counted by Mr. Vijay Yadav / AVS & Associates.The company's voting result (opens in a new tab)

  1. Adoption of Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2026 together with the Reports of the Board of Directors and the Auditors
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.04% · other public 0.00%

    Turnout: all 61.66% · promoters 99.98% · institutions 36.02% · other public 42.90%

  2. Declaration of Final Dividend of 100% i.e. ₹ 1.00 per equity share on face value of ₹ 1/- each for the financial year ended March 31, 2026.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 61.67% · promoters 99.98% · institutions 36.08% · other public 42.90%

  3. Re-Appointment of Mr. Narsimha Shibroor Kamath (DIN: 00140593) as a Managing Director & CEO, liable to retire by rotation, who has offered himself for re-appointment.
    OrdinaryPromoters have an interest in it
    97.68% for2.32% against

    Against: promoters 0.00% · institutions 14.45% · other public 0.00%

    Turnout: all 61.67% · promoters 99.98% · institutions 55.97% · other public 35.44%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 9 May 2026, 2 resolutions

45,804 shareholders on the register on 7 Apr 2026; votes counted by Mr.Vijay Yadav / AVS & Associates.The company's voting result (opens in a new tab)

  1. APPOINTMENT OF MR. VIJAYANARAYANAN MAHADEVAN (DIN: 06639177) AS A DIRECTOR IN THE CAPACITY OF NON-EXECUTIVE AND INDEPENDENT DIRECTOR OF THE COMPANYFOR A TERM OF FIVE YEARS
    Special
    99.72% for0.28% against

    Against: promoters 0.00% · institutions 5.90% · other public 0.00%

    Turnout: all 49.14% · promoters 92.45% · institutions 15.77% · other public 28.30%

  2. APPOINTMENT OF MR. DEEPAK RAMESHCHANDRA SHAH (DIN: 06954206) AS A DIRECTOR IN THECAPACITY OF NON-EXECUTIVE AND INDEPENDENT DIRECTOR OF THE COMPANYFOR A TERM OF FIVE YEARS
    Special
    99.72% for0.28% against

    Against: promoters 0.00% · institutions 5.90% · other public 0.01%

    Turnout: all 49.14% · promoters 92.45% · institutions 15.77% · other public 28.30%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 29 Jan 2026, 1 resolution

44,167 shareholders on the register on 26 Dec 2025; votes counted by Mr. Vijay Yadav / AVS & Associates.The company's voting result (opens in a new tab)

  1. Appointment of Mr. Narsimha Shibroor Kamath (DIN:00140593) as ‘Director’ in the capacity of ‘Managing Director’ of the company.
    SpecialPromoters have an interest in it
    99.90% for0.10% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.41%

    Turnout: all 60.21% · promoters 99.33% · institutions 48.17% · other public 34.47%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 31 Jul 2025, 4 resolutions

46,979 shareholders on the register on 24 Jul 2025; present: 4 promoters and 91 others; votes counted by Mr. Vijay Yadav / AVS & Associates.The company's voting result (opens in a new tab)

  1. Adoption of Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2025 together with the Reports of the Board of Directors and the Auditors thereon
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 58.21% · promoters 99.83% · institutions 45.86% · other public 30.95%

  2. Declaration of Final Dividend of 50 percent i.e. Rs. 0.50 paisa per equity share on face value of Rs. 1 each for the financial year ended March 31, 2025.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 58.22% · promoters 99.83% · institutions 45.91% · other public 30.95%

  3. Re-appointment of Dr. Vibha Gagan Sharma (DIN: 02307289) as a Director of the Company, who retires by rotation, and being eligible offered herself for re-appointment.
    OrdinaryPromoters have an interest in it
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.02% · other public 0.01%

    Turnout: all 55.78% · promoters 92.94% · institutions 45.91% · other public 30.95%

  4. Appointment of Messers. AVS & Associates, Company Secretaries as Secretarial Auditors of the Company.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 58.22% · promoters 99.83% · institutions 45.91% · other public 30.95%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 11 Jun 2025, 2 resolutions

50,199 shareholders on the register on 9 May 2025; votes counted by Mr. Vijay Yadav / AVS & Associates.The company's voting result (opens in a new tab)

  1. Approval of the issuance of sweat equity shares to Mr. Gagan Harsh Sharma (DIN: 07939421), Managing Director of the Company
    SpecialNot passedRecorded as not passed although most votes were for it; no reason is givenPromoters have an interest in it
    70.87% for29.13% against

    Against: promoters 0.00% · institutions 84.41% · other public 2.05%

    Turnout: all 26.44% · promoters 0.00% · institutions 44.56% · other public 39.26%

  2. Approval of the issuance of sweat equity shares to Mr. Vishal Vijay Rao, Vice-President of the Company
    SpecialNot passedRecorded as not passed although most votes were for it; no reason is givenPromoters have an interest in it
    70.90% for29.10% against

    Against: promoters 0.00% · institutions 84.41% · other public 2.00%

    Turnout: all 26.44% · promoters 0.00% · institutions 44.56% · other public 39.26%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 25 Jul 2024, 10 resolutions

Present: 119 promoters and 3 others.The company's voting result (opens in a new tab)

  1. Adoption of Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2024 together with the reports of the Board of Directors and the Auditors thereon.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 56.48% · promoters 100.00% · institutions 36.49% · other public 31.75%

  2. Declaration of Final Dividend of 50% i.e. Re. 0.50 paisa per equity share on face value of Rs. 1/- each for the financial year ended March 31, 2024.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.02%

    Turnout: all 56.49% · promoters 100.00% · institutions 36.54% · other public 31.75%

  3. Re-Appointment of Mrs. Shruti Vishal Rao (DIN: 00731501) as a Director, liable to retire by rotation, who has offered herself for reappointment
    OrdinaryPromoters have an interest in it
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.04%

    Turnout: all 56.49% · promoters 100.00% · institutions 36.54% · other public 31.75%

  4. Appointment of Dr. Nandkumar Kashinath Chodankar (DIN: 02736718) as an Independent Director of the Company
    Special
    99.98% for0.02% against

    Against: promoters 0.00% · institutions 0.15% · other public 0.05%

    Turnout: all 49.91% · promoters 100.00% · institutions 2.85% · other public 31.75%

  5. Re-appointment of Mr. Gagan Harsh Sharma (DIN: 07939421) as a Managing Director of the Company
    SpecialPromoters have an interest in it
    87.35% for12.65% against

    Against: promoters 0.00% · institutions 100.00% · other public 0.10%

    Turnout: all 56.49% · promoters 100.00% · institutions 36.54% · other public 31.75%

  6. Re-appointment of Dr. Vibha Gagan Sharma (DIN: 02307289) as a Whole-Time Director of the Company
    SpecialPromoters have an interest in it
    88.35% for11.65% against

    Against: promoters 0.00% · institutions 92.20% · other public 0.02%

    Turnout: all 56.49% · promoters 100.00% · institutions 36.54% · other public 31.75%

  7. Re-appointment of Mrs. Shruti Vishal Rao (DIN: 00731501) as a Whole-Time Director of the Company
    SpecialPromoters have an interest in it
    88.35% for11.65% against

    Against: promoters 0.00% · institutions 92.20% · other public 0.02%

    Turnout: all 56.49% · promoters 100.00% · institutions 36.54% · other public 31.75%

  8. Re-appointment of Ms. Shilpa Bhatia (DIN: 08695595) as an Independent Director of the Company
    Special
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.04%

    Turnout: all 56.49% · promoters 100.00% · institutions 36.54% · other public 31.75%

  9. Re-appointment of Mr. Vishal Vijay Rao as a VicePresident of the Company, a relative of Directors holding office or place of profit in the Company
    SpecialPromoters have an interest in it
    99.06% for0.94% against

    Against: promoters 0.00% · institutions 7.40% · other public 0.04%

    Turnout: all 56.49% · promoters 100.00% · institutions 36.54% · other public 31.75%

  10. Approval for Material Related Party Transaction(s) with Greenlife Pharmaceuticals Limited
    OrdinaryPromoters have an interest in it
    69.08% for30.92% against

    Against: promoters 0.00% · institutions 92.20% · other public 0.72%

    Turnout: all 21.60% · promoters 0.00% · institutions 36.54% · other public 31.72%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 19 Jul 2023, 4 resolutions

Present: 2 promoters and 64 others.The company's voting result (opens in a new tab)

  1. doption of Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2023 together with the Reports of the Board of Directors and the Auditors thereon.
    Ordinary
    87.54% for12.46% against

    Against: promoters 0.00% · institutions 70.70% · other public 0.00%

    Turnout: all 53.14% · promoters 99.98% · institutions 40.45% · other public 20.75%

  2. Declaration of Final Dividend of 50% i.e. ₹ 0.50 paisa per equity share on face value of Rs. 1/- each for the financial year ended March 31, 2023.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 53.16% · promoters 99.98% · institutions 40.52% · other public 20.75%

  3. Re-appointment of Dr. Vibha Gagan Sharma (DIN: 02307289) as a Director of the Company, who retires by rotation, and being eligible offered herself for re-appointment.
    Ordinary
    95.50% for4.50% against

    Against: promoters 0.00% · institutions 25.30% · other public 0.21%

    Turnout: all 53.16% · promoters 99.98% · institutions 40.52% · other public 20.75%

  4. Approval for Material Related Party Transaction(s) with Greenlife Pharmaceuticals Limited
    OrdinaryPromoters have an interest in it
    63.17% for36.83% against

    Against: promoters 0.00% · institutions 70.57% · other public 0.21%

    Turnout: all 18.03% · promoters 0.00% · institutions 40.52% · other public 20.72%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

How mutual funds voted

Fund houses must disclose how they vote at every meeting of a company they hold.

Mutual fund votes, meeting of 9 May 2026, 2 fund houses

  • APPOINTMENT OF MR. VIJAYANARAYANAN MAHADEVAN (DIN: 06639177) AS A DIRECTOR IN THE CAPACITY OF NON-EXECUTIVE AND INDEPENDENT DIRECTOR OF THE COMPANYFOR A TERM OF FIVE YEARS
    2 for0 against
  • APPOINTMENT OF MR. DEEPAK RAMESHCHANDRA SHAH (DIN: 06954206) AS A DIRECTOR IN THECAPACITY OF NON-EXECUTIVE AND INDEPENDENT DIRECTOR OF THE COMPANYFOR A TERM OF FIVE YEARS
    2 for0 against

Mutual fund votes, meeting of 29 Jan 2026, 2 fund houses

  • Appointment of Mr. Narsimha Shibroor Kamath (DIN:00140593) as ‘Director’ in the capacity of ‘Managing Director’ of the company.
    2 for0 against
4 earlier meetings

Mutual fund votes, meeting of 31 Jul 2025, 2 fund houses

  • Adoption of Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2025 together with the Reports of the Board of Directors and the Auditors thereon
    2 for0 against
  • Declaration of Final Dividend of 50 percent i.e. Rs. 0.50 paisa per equity share on face value of Rs. 1 each for the financial year ended March 31, 2025.
    2 for0 against
  • Re-appointment of Dr. Vibha Gagan Sharma (DIN: 02307289) as a Director of the Company, who retires by rotation, and being eligible offered herself for re-appointment.
    2 for0 against
  • Appointment of Messers. AVS & Associates, Company Secretaries as Secretarial Auditors of the Company.
    2 for0 against

Mutual fund votes, meeting of 11 Jun 2025, 2 fund houses

  • Approval of the issuance of sweat equity shares to Mr. Gagan Harsh Sharma (DIN: 07939421), Managing Director of the Company
    Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund
    • Bandhan Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Governance Concern: Issuance of sweat equity proposed for performing duties in the ordinary course.
    0 for2 against
  • Approval of the issuance of sweat equity shares to Mr. Vishal Vijay Rao, Vice-President of the Company
    Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund
    • Bandhan Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Governance Concern: Inadequate justification for proposed appointee; No clarity of role and responsibility w.r.t. the Ghana subsidiary.
    0 for2 against

Mutual fund votes, meeting of 25 Jul 2024, 1 fund house

  • Adoption of Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2024 together with the reports of the Board of Directors and the Auditors thereon.
    1 for0 against
  • Declaration of Final Dividend of 50% i.e. Re. 0.50 paisa per equity share on face value of Rs. 1/- each for the financial year ended March 31, 2024.
    1 for0 against
  • Re-Appointment of Mrs. Shruti Vishal Rao (DIN: 00731501) as a Director, liable to retire by rotation, who has offered herself for reappointment
    1 for0 against
  • Appointment of Dr. Nandkumar Kashinath Chodankar (DIN: 02736718) as an Independent Director of the Company
    Against Motilal Oswal Mutual Fund
    • Motilal Oswal Mutual FundNo concern on merit of Director. Non-Compliant with SEBI LODR: Prior approval of shareholders not sought for continuation after attaining the age of 75 years. No specific justification for continuation.
    0 for1 against
  • Re-appointment of Mr. Gagan Harsh Sharma (DIN: 07939421) as a Managing Director of the Company
    Against Motilal Oswal Mutual Fund
    • Motilal Oswal Mutual FundCompliant with law. No concern on merit of Director. Governance concern: No absolute cap on variable pay. Gender biased remuneration.
    0 for1 against
  • Re-appointment of Dr. Vibha Gagan Sharma (DIN: 02307289) as a Whole-Time Director of the Company
    Against Motilal Oswal Mutual Fund
    • Motilal Oswal Mutual FundCompliant with law. No concern on merit of Director. Governance concern: No absolute cap on variable pay.
    0 for1 against
  • Re-appointment of Mrs. Shruti Vishal Rao (DIN: 00731501) as a Whole-Time Director of the Company
    Against Motilal Oswal Mutual Fund
    • Motilal Oswal Mutual FundCompliant with law. No concern on merit of Director. Governance concern: No absolute cap on variable pay.
    0 for1 against
  • Re-appointment of Ms. Shilpa Bhatia (DIN: 08695595) as an Independent Director of the Company
    1 for0 against
  • Re-appointment of Mr. Vishal Vijay Rao as a VicePresident of the Company, a relative of Directors holding office or place of profit in the Company
    1 for0 against
  • Approval for Material Related Party Transaction(s) with Greenlife Pharmaceuticals Limited
    Against Motilal Oswal Mutual Fund
    • Motilal Oswal Mutual FundCompliant with Law. Governance Concern: Basis for Arm’s Length pricing not disclosed.
    0 for1 against

Mutual fund votes, meeting of 19 Jul 2023, 1 fund house

  • doption of Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2023 together with the Reports of the Board of Directors and the Auditors thereon.
    Against Motilal Oswal Mutual Fund
    • Motilal Oswal Mutual FundUnqualified statements. Non-Compliant with Companies Act, 2013 & SEBI LODR Regulations: Non-disclosure of financial statements of Subsidiaries on the website.
    0 for1 against
  • Declaration of Final Dividend of 50% i.e. ₹ 0.50 paisa per equity share on face value of Rs. 1/- each for the financial year ended March 31, 2023.
    1 for0 against
  • Re-appointment of Dr. Vibha Gagan Sharma (DIN: 02307289) as a Director of the Company, who retires by rotation, and being eligible offered herself for re-appointment.
    1 for0 against
  • Approval for Material Related Party Transaction(s) with Greenlife Pharmaceuticals Limited
    Against Motilal Oswal Mutual Fund
    • Motilal Oswal Mutual FundNo concern on merit of proposed transactions. Technical Non-compliance with SEBI Circular: Omnibus approval of RPTs for a period of more than one year
    0 for1 against

Each fund house counted once, from its own disclosure; the reasons are its own words.

Tax disputes

Reported in the filing for the quarter to Jun 2026.

  • Tax disputeDeputy Commissioner of Income TaxSince 13 Dec 2026
    OGE passed for the AY 2014-15 with certain errors by Ld. Assessing officer. Rectification has been filed vide rectification letter dtd. 27.02.2026
    At the filing before: Assessment Year 2014-15 Order giving effect of Appealate order received on 22.09.2025
  • Tax disputeAssistant Commissioner of Income Tax, Central Circle 7(1), MumbaiSince 6 May 2021
    The company has opted for Direct Tax Vivad Se Vishwas Scheme, 2024 for the Assessment Year 2017-18 and filed Form 1 declaration dated 29.01.2025 on eportal. Accepting application of Company, Form 4 has been issued by Hon'able Pr. CIT on 3rd April 2025. We have discharge additional Income tax liability as on 09.06.2025 as a secondary adjustment pursuant to adjustments u/s 92CA(3). Tax Refund is awaited.MoreLess
    At the filing before: Assessment Year 2017-18,Appeal withdrawn by opting for settlement of dispute under DTVSV Scheme 2024
  • Tax disputeAssistant Commissioner of Income Tax, Central Circle 7(1), MumbaiSince 22 Oct 2021
    The company has opted for Direct Tax Vivad Se Vishwas Scheme, 2024 for the Assessment Year 2018-19 and filed Form 1 declaration dated 29.01.2025 on eportal. Accepting application of Company, Form 4 has been issued by Hon'able Pr. CIT on 3rd April 2025. We have discharge additional Income tax liability as on 09.06.2025 as a secondary adjustment pursuant to adjustments u/s 92CA(3). The DTVSV tax refund of Rs.82,99,760/- due to the company for the AY 2018-19 has been wrongly adjusted against the demand liability of AY 2014-15 vide challan no.42874 dtd.31.12.2025. The company has filed rectification letter on 27.02.2026 to arrive at correct position of refund for the year under consideration.MoreLess
    At the filing before: Assessment Year 2018-19: Appeal withdrawn by opting for settlement of dispute under DTVSV Scheme 2024
  • Tax disputeAssistant Commissioner of Income Tax, Central CircleSince 30 Mar 2025
    Company on 15.04.2025, had uploaded its objection for reopening. We believed that since there is no escapement of income, assessment can not be reopened. Instead the JAO has ordered reopening of assessement. The company has filed entire submission to the notice u/s 142(1) of the Act on 07.07.2026MoreLess
    At the filing before: The Company has received notice dated 30-03-2025 u/s 148A for reopening of assessment u/s 147 for AY 2019-20.The Company has received further notice dtd.06-06-2026 u/s 142(1) of the Income Tax Act, 1961 for the AY 2019-20MoreLess
  • Tax disputeAssistant Commissioner of Income Tax, Central CircleSince 31 Mar 2026
    The company has replied to the notice u/s 148A of the act on 06.04.2026.On 09-06-2026, AO has passed order u/s 148A(3) for reopening the assessment on the grounds that deduction u/s 80G with respect to CSR-funded donations amounting to Rs.1,02,50,000/- wrongly allowed in the assessment.MoreLess
    At the filing before: The company has received show cause notice for proceedings u/s 148A of the income tax act dtd.31.03.2026 for the AY 2020-21.
  • Tax disputeThe company has replied to the notice u/s 148A of the act on 06.04.2026.On 09-06-2026, AO has passed order u/s 148A(3) for reopening the assessment on the grounds that deduction u/s 80G with respect to CSR-funded donations amounting to Rs.1,02,50,000/- wrongly allowed in the assessment.Since 7 Jul 2025
    here is an addition of Rs.1.50 lakhs in the final assessment order. However, the Assessing officer has erred in passing order by not allowing certain legitimates deductions. Due to which wrong demand of Rs.23,50,980/- has been outstanding on IT portal. The rectification has been filed by the company on 18.03.2026MoreLess
    At the filing before: Assessment Year 2024-25:Assessment proceedings concluded and final order u/s 143(3) of the Income tax Act received on 14-03-2026.
  • Tax disputeIncome Tax Officer, TDS Circle 1(1), MumbaiSince 26 Jun 2024
    Adjournment has been taken for modifications and corrections are undertaken on Traces portal.
    At the filing before: Company has compiled data yearwise by tagging appropriate lower deduction certificates against demand raised due to shortfall in TDS deduction as well as done required rectifications on traces portal to delete demand raised on account of Inoperative PAN of the employees.MoreLess
  • Tax disputeSuperintendent of CGST, Range:I, Div:VII, Vadodara-I CommissionerateSince 30 Aug 2024
    Writ Petition filed before Hon'ble Bombay High Court
    At the filing before: Refund application has been rejected by The Asst. Commissioner of CGST, Appeal filed before Commissioner (Appeals-II) Mumbai against refund rejection order who upheld order passed by The Asst. Commissioner of CGST and dismissed Appeal vide O-I-A No. 474/VKP/ADC/APPEALS-II/ME/24-25 Dt. 27/02/2025MoreLess
7 more
  • Tax disputeUnion of India & OthersSince 9 Oct 2023
    Writ Petition filed before Hon'ble Bombay High Court
    At the filing before: Rebate applications rejected by The Asst. Commissioner, Rebate, O-I-O is upheld by Commissioner (Appeals), Mumbai, and The Principal Commissioner & Ex. Officio, Additional Secretary, The Govt., of India, Revisional AuthorityMoreLess
  • Tax disputeUnion of India & OthersSince 18 Jul 2024
    Writ Petition filed before Hon'ble Bombay High Court
    At the filing before: Additional Commissioner, Central Excise, Raigad has issued Show Cause cum Demand Notices to recover sanctioned rebate which were confirmed by The Joint Commissioner but were set aside by The Commissioner (Appeals) after which Dept. had filed Revision Application to the RA Authority (GOI) who again upheld demand raised vide Show Cause cum Demand Notices issued by Additional Commissioner.MoreLess
  • Tax disputeUnion of India & OthersSince 31 Oct 2018
    Writ Petition filed before Hon'ble Bombay High Court
    At the filing before: Deputy Commissioner, C. E. rejected refund application, after which Commissioner (Appeals) and CESTAT also upheld order issued by Dy. Commissioner.
  • Tax disputeJoint Commissioner of CGST and Central Excise, Mumbai East, MumbaiSince 30 Jun 2025
    In view of the stay granted by Hon'ble Bombay High Court in similar matter, authority has kept the subject SCN in Abeyance in terms of section 75(11) of the Act.
    At the filing before: Joint Commissioner of CGST and Central Excise, Mumbai East, Mumbai has issued Show Cause Notice with regards to availing IGST Refund on exports in contravention of Rule 96(10) of the CGST Rules, 2017 during FY 2018-19.MoreLess
  • Tax disputeJoint Commissioner of CGST and Central Excise, Mumbai East, MumbaiSince 30 Sep 2025
    In view of the stay granted by Hon'ble Bombay High Court in similar matter, authority has kept the subject SCN in Abeyance in terms of section 75(11) of the Act.
    At the filing before: Joint Commissioner of CGST and Central Excise, Mumbai East, Mumbai has issued Show Cause Notice with regards to availing IGST Refund on exports in contravention of Rule 96(10) of the CGST Rules, 2017 during the FY 2019-20 to 2023-24.MoreLess
  • Tax disputeAsst. Commissioner of State Tax, Mazgaon, MumbaiSince 6 Nov 2025
    We apprared before Asst. Commissioner of State Tax and have submitted required documents, awaiting for further proceedings Order.
    At the filing before: Asst. Commissioner of State Tax, Mazgaon, Mumbai has issued Sommons to appear along with details of; i. Payment realization details (FIRC, BRC) of export invoices for which refund had been claimed for the F.Y. 2023-24 & 2024-25. ii. ITC register (Annexure-B) in respect of refund claimed for the F.Y. 2023-24 & 2024-25. iii. Sample copy of export invoices and purchase invoicesMoreLess
  • Tax disputeSuperintendent of CGST, Range:I, Div:VII, Vadodara-I CommissionerateSince 15 May 2026
    We are in process of filing of reply to the said Notice in Form GST ASMT-10
    At the filing before: GST Jurisdictional Authorities, Vadodara issued Return discrepancy Notice in Form GST ASMT-10 for FY 2022-23. AS per Notice, we have availed excess ITC in Form GSTR3B than the same available as per Form GSTR2B for the same tax period.MoreLess

In the company's own words, from its latest governance filing.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

  • Received
  • Resolved

Open at the quarter's end

At most 1 complaint open, quarter to Mar 2026.
The board is made up as the listing rules require
No
The board has a regular chairperson
Yes
The company has a risk management committee
Yes
The chair is related to the managing director
No
The filing has a part on fines and penalties
No
The filing has a part on tax disputes
Yes
There was a cyber security incident in the quarter
No

The company's own answers in its filing.